Onco. Treatments Pvt Ltd

03/02/2026

For more information on Pyrexar Hyperthermia System please email: info@oncotreatments.com.

Paul Turner, Pyrexar

03/02/2026

Nyd de videoer og den musik, du holder af, upload originalt indhold, og del det hele med venner, familie og verden på YouTube.

03/02/2026

Paul Turner, CTO of Pyrexar Medical, explains the principals of deep regional hyperthermia using radio frequency

03/02/2026

3 reasons to add Hyperthermia to your cancer treatment.

Rational for adding thermal oncology to your cancer center

03/02/2026

Pyrexar Bsd-2000 MRI based Hyperthermia device

Pyrexar manufactures cancer treatment systems that use heat to disrupt the cancer tumor micro-environment to make radiotherapy and chemotherapy more effective.

03/02/2026

Paul Turner, Pyrexar

03/02/2026

Patient with Stage IV Pancreatic cancer gets new lease on life with Hyperthermia treatment.

Video from Pyrexar Youtube Channel

03/02/2026

Paul Turner, CTO of Pyrexar Medical, explains the principals of deep regional hyperthermia using radio frequency

Video from Pyrexar Youtube Channel

24/12/2025

PYREXAR BSD-500 Superficial Hyperthermia
a versatile, fully self-contained treatment system in a mobile configuration or maximum treatment flexibility of superficial tumors within 1” of skin surface

Portable
• No shielding room needed
• FDA Approved for palliative
treatment of certain tumors
• Delivers both superficial and
interstitial hyperthermia

Choose from 3 sizes of interchangeable superficial applicators and take advantage of up to 24 interstitial antennas for use with brachytherapy. System software provides monitoring and control of up to 8 temperature sensors. Master power control adjustable at the touch of a button.

24/12/2025

PYREXAR

BSD-2000 3D/MR Deep Regional Hyperthermia
MR image guided real-time non-invasive thermometry and Integration with 1.5 Tesla MR system.

Three-Dimensional Hyperthermia with Non-Invasive Magnetic Resonance (MR) Imaging Capabilities

The BSD-2000 3D/MR System combines the sophisticated treatment delivery and control capabilities of the Sigma Eye Applicator with the non-invasive patient and treatment monitoring capabilities of the independently operated MR imaging System.

To minimize the interaction between these two systems, special filters are installed in both systems, thus eliminating interference problems. The BSD-2000 3D/MR and the Sigma Eye MR System provide a high degree of RF isolation between the hyperthermia therapy and MR imaging device.

Non-invasive MRI during hyperthermia treatments provides the capability to monitor changes in temperature

Electromagnetic (EM) phased array hyperthermia applicator with 3D heating pattern and shaping control 3D, patient-specific, treatment planning workstation currently available through our partner Sennewald.de

Non-invasive magnetic resonance (MR) imaging
3D optimization of radiated power amplitudes and phases

24/12/2025

Three-Dimensional Hyperthermia with Non-Invasive Magnetic Resonance (MR) Imaging Capabilities

The BSD-2000 3D/MR System combines the sophisticated treatment delivery and control capabilities of the Sigma Eye Applicator with the non-invasive patient and treatment monitoring capabilities of the independently operated MR imaging System.

To minimize the interaction between these two systems, special filters are installed in both systems, thus eliminating interference problems. The BSD-2000 3D/MR and the Sigma Eye MR System provide a high degree of RF isolation between the hyperthermia therapy and MR imaging device.

Non-invasive MRI during hyperthermia treatments provides the capability to monitor changes in temperature
Electromagnetic (EM) phased array hyperthermia applicator with 3D heating pattern and shaping control 3D, patient-specific, treatment planning workstation currently available through our partner Sennewald.de

Non-invasive magnetic resonance (MR) imaging
3D optimization of radiated power amplitudes and phases

24/12/2025

Three-Dimensional Hyperthermia Permits Superior Targeting and Optimal Results
The BSD-2000/3D provides targeted deep regional therapeutic hyperthermia to solid tumors by applying radiofrequency (RF) energy. The BSD-2000/3D delivers energy to a patient using a power source and an array of multiple antennae that surround the patient’s body. The twenty-four dipole antennas of the Sigma Eye maximize the 3D energy convergence at the targeted treatment location.

The BSD-2000/3D was designed to provide an optimized heating zone targeted to the tumor region by utilizing the adjustment of frequency, phase, and amplitude from multiple power sources. Dynamic 3D control and steering of the heating pattern size, shape, depth, and position provide optimized heating since the electromagnetic energy can be targeted specifically at the tumor region. The focus is not fixed at the center of the applicator, providing the system operator with significantly more freedom in positioning the applicator's heating region. The BSD 2000/3D hyperthermia system is designed particularly for treating tumors in hard-to-reach locations. This model is currently sold outside of the U.S.

How is 3D Hyperthermia Applied?

The targeted treatment area of the patient's body is enclosed by an eye-shaped applicator. Phase and amplitude steering is utilized to create the heating focus within the applicator.

The 3D technology utilizes 24 dipole antennas of the Sigma Eye driven by 12 RF power channels to optimize the targeted heating.

The 24 dipoles are arranged in three rings of eight antennas each. By varying the phase and amplitude of each of the 12 input channels, the operator can enhance the heating in the tumor and reduce the heating in non-target tissues.